Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial
已完结10由 syg1026 发布于 2025/5/26 22:53:49
DOI:10.1016/j.ahj.2024.05.019
作者:Lei Song MD , Changdong Guan MSc , Mengyue Yu MD , Zhongwei Sun MSc , Guosheng Fu MD , Yong He MD , Shaobin Jia MD , Jiyan Chen MD , Feng Qi MD , Jie Bai M
文献类型:期刊论文
补充材料:只需要正文